Future of Healthcare Week Asia
Asia’s healthcare tomorrow: Pivoting back to non-communicable disease
Asia’s healthcare tomorrow: Pivoting back to non-communicable disease
Despite NCDs accounting for 41 million deaths annually, they are still healthcare's 'blind spot', expert says.
Join the community
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 4. China’s healthcare defies Hang Seng slump with 0.9% gain 5. How can healthcare providers make AI pay off?Resource Center
Partner Events
Event News
Medical Taiwan 2026 closes with $168.7m in business opportunities
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential